Evidence map›Paper›PMID 22777830›Full record

ArticleProteins2012

The catalytic domain of the germination-specific lytic transglycosylase SleB from Bacillus anthracis displays a unique active site topology.

Xing Jing, Howard R Robinson, Jared D Heffron, David L Popham, Florian D Schubot

Abstract read
In one paragraph

Article in Proteins, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Structural and functional analysis ofMicrobiology (Reading, England) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Lytic transglycosylases: concinnity in concision of the bacterial cell wall.Critical reviews in biochemistry and molecular biology · 2017
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Bacterial cell-wall recycling.Annals of the New York Academy of Sciences · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xing JingVirginia Tech, Department of Biological Sciences, Life Sciences, Blacksburg, Virginia 24061, USA.
Howard R Robinson
Jared D Heffron
David L Popham
Florian D Schubot

Funding

Case Center for Synchrotron BiosciencesP30EB009998 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI CHANCE, MARK R · 2009 to 2018
$8.4M
SPORE PEPTIDOGLYCAN DEGRADATION IN BACILLUS ANTHRACISR21AI060726 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI POPHAM, DAVID L · 2004 to 2005
$492k
NIAID NIH HHS AI060726NIAID NIH HHS R21 AI060726NIBIB NIH HHS P30 EB009998
6 · The paper itself

Abstract

Bacillus anthracis produces metabolically inactive spores. Germination of these spores requires germination-specific lytic enzymes (GSLEs) that degrade the unique cortex peptidoglycan to permit resumption of metabolic activity and outgrowth. We report the first crystal structure of the catalytic domain of a GSLE, SleB. The structure revealed a transglycosylase fold with unique active site topology and permitted identification of the catalytic glutamate residue. Moreover, the structure provided insights into the molecular basis for the specificity of the enzyme for muramic-δ-lactam-containing cortex peptidoglycan. The protein also contains a metal-binding site that is positioned directly at the entrance of the substrate-binding cleft.

Indexed as

AmidohydrolasesAmino Acid SequenceBacillus anthracisBacterial ProteinsCatalytic DomainGlutamic AcidHydrolasesModels, MolecularMolecular Sequence DataPeptidoglycanPeptidoglycan GlycosyltransferaseAmidohydrolasesBacterial ProteinsCwlJ protein, Bacillus subtilisGlutamic AcidHydrolasesPeptidoglycanPeptidoglycan GlycosyltransferaseSleB protein, Bacillus

Identifiers

PMID22777830
PMCPMC3621120

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.